Patients with chronic hypoparathyroidism (hypoPT) experience a significant burden from complications related to decreased serum calcium, increased phosphorus, and absent or deficient PTH. Most importantly, patients with chronic hypoPT managed with conventional therapy of oral calcium and active vitamin D supplementation have adverse kidney outcomes of nephrolithiasis/kidney stones, nephrocalcinosis, and CKD. The advent of evolving approaches to mitigate hypopPT-related kidney complications is a paradigm shift in the management of this rare and highly disabling condition. Led by experts in the field and with the participation of patient advocates, this immersive discussion will highlight the evolution of management approaches toward reducing kidney-related complications and improving quality of life for patients with chronic hypoPT.
- Provider:Endocrine Society
- Activity Link: https://education.endocrine.org/URL/ENDO24_HypoPT_Enduring
- Start Date: 2024-07-24 05:00:00
- End Date: 2024-07-24 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Amolyt Pharma - Amount: 498994.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Endocrinology, Diabetes, and Metabolism